To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer ends JV with Hisun

Pfizer Inc. (NYSE:PFE) sold its 49% stake in Chinese JV Hisun-Pfizer Pharmaceuticals Co. Ltd. to Sapphire I (HK) Holdings Ltd. In 2012, Pfizer formed the JV with Zhejiang Hisun Pharmaceutical Co. Ltd. (Shanghai:600267)

Read the full 333 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE